Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript February 22, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.2. Amylyx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. […]

Related Keywords

Phoenix , Arizona , United States , Canada , America , Josh Cohen , Linda Arsenault , Camille Bedrosian , Geoff Meacham , Washington University , Most Valuable Luxury Companies , Chief Medical Officer , New England Journal , Rating Scale Revised , Progressive Supranuclear Palsy , Chief Human Resources , Valuable Luxury Companies , Back Out , Amylyx Pharmaceuticals , Neurodegenerative Diseases , Living With Als , Fourth Quarter , Lindsey Allen , Relyvrio ,